Product Images Gabapentin

The text is a chart or graph showing the mean pain score during a 4-week dose titration period and a 4-week fixed-dose period. There are two groups: the placebo group and the Gabapentin group, who were given a dose of 3600 mg/day. The chart indicates that the Gabapentin group had significantly lower pain scores compared to the placebo group.*

This is a clinical chart showing the mean pain score during a 3-week dose titration period and a 4-week fixed dose period of a placebo group, a group receiving 1800 mg/day of Gabapentin, and a group receiving 2400 mg/day of Gabapentin. The chart shows a decrease in mean pain score in all groups, especially in the Gabapentin groups, with statistical significance (p<0.01).*

The text provides a chart with the percentage of responders at the endpoint for Study 1 and Study 2. It also includes the statistical significance levels for each group. However, the content of the chart is not clear due to missing labels or context.*

This is a description of a medication package that contains Gabapentin capsules, with each capsule having 100 mg of the active ingredient. The package has an NDC number of 16590-101-90 and a lot number of SAHPLE. The medication is distributed by a company called R USA Ganesle and is labeled by a company called Hig By belh. The package has a discard after date of 01113.*